T1DM: Vitamin D Supplementation (2023)
Author and Year:
Nafei L, Ali Kadhim K, et al. 2017
PubMed ID:
Article Title:
Evaluation the Effect of Vitamin D3 on Glycemic Indices on Iraqi Children with Type 1 DM.
Authors:
Nafei L, Ali Kadhim K, Muaffaq Said A, Hameed Ghani S.
Journal:
International Journal of Pharmaceutical Sciences Review and Research
Year of publication:
2017
Volume:
42
Issue:
1
Page numbers:
134-143
Study Design:
Randomized Controlled Trial
Risk of Bias Assessment Rating:
Some concerns
Inclusion Criteria:
Iraqi children; newly diagnosed T1DM (not more than 1 year duration of disease); age 4-12 years old.
Exclusion Criteria:
T2DM; T1DM with history of autoimmune or chronic inflammatory disease; CRF or hepatic disease; diabetic complications; uncontrolled diabetes; any type of cancer; taking chemotherapy or any other drugs.
Research Purpose:
To evaluate the possible correlation between serum vitamin D3 (cholecalciferol) levels with serum fasting blood glucose, serum HbA1c, serum insulin levels, serum C-peptide levels related to newly diagnosed pediatric patients with type 1 diabetes mellitus.
Blinding efforts:
Not reported
Study Location:
Iraq
Source(s) of Funding:
University/Hospital
Please specify names of funders:
AL-Mustansiriyah University, Baghdad-Iraq